Provider review
WeightCare review
Publishes real milligram bands on both molecules, one of them a microdose band.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$249/mo microdose at 0.25–1 mg/wk
Visit WeightCareOnly the highest of the three figures in its comparison strip is a month-to-month rate; the other two are prepay rungs shown in the same register.
Price as published
WeightCare
$249/mo microdose at 0.25–1 mg/wk
FDA warning letter · WeightCare · February 2026 · addressed to Weightless Medical LLC dba WeightCare. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Charges less for less
- Dispensed
- Compounded, a 503B outsourcing facility, not named
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Stating the dose band a price covers is the single most useful thing a provider here can do, and WeightCare does it on both molecules — including a microdose band priced beneath the all-doses band. That makes the offer legible in a way most of this category is not. The pricing display then undoes some of that work: three figures sit side by side in one strip and only the highest is a monthly rate, the discounted three-month tirzepatide rate is a starter that renews substantially higher, and the top dose band is not sold monthly at all. A warning letter is disclosed below.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the milligram band the price covers stated rather than implied
- You want a microdose band that is genuinely priced beneath the standard band
- You want pharmacy accreditation named specifically rather than described as licensed
Look elsewhere if
- You are reading the comparison strip as three monthly options — only one of them is
- You expect the discounted three-month rate to hold at renewal, because it does not
- You expect to titrate to the top band, which is not sold on a monthly plan at all
What it actually costs
Price as published
$249/mo microdose at 0.25–1 mg/wk
- Vs median
- $74/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Charges less for less
Publishes a named low-dose product at a lower price than its own full-dose equivalent. Taking a smaller amount genuinely costs less here, which is the structure this page is looking for.
42 of the 548 programs here price a small dose this way. Publishes real milligram bands against the prices on both molecules, with a microdose band priced beneath the all-doses band — one of very few providers that states the dose a price covers at all. Only the highest of the three figures in its comparison strip is a month-to-month rate, and the high-dose plan is not sold monthly at all.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Publishes actual milligram bands against its prices on both molecules — 0.25–1 mg/week for the semaglutide microdose, 2.5–5 mg/week for the tirzepatide microdose
- The microdose is a separately priced product on both molecules and is genuinely cheaper than the standard band
- Names its pharmacy accreditation specifically (FDA-registered, PCAB-accredited) rather than saying "licensed"
- Publishes quality-testing documentation for potency and sterility against a named USP standard
- A real month-to-month rung exists on the standard products, so the ladder can be read against a genuine monthly rate
- Multi-year operating history with a published member count rather than an anonymous launch
Pharmacy, labs and oversight
WeightCare says it uses a 503B outsourcing facility, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What WeightCare publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses a 503B outsourcing facility, but does not say which one.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to WeightCare in February 2026. It is addressed to Weightless Medical LLC dba WeightCare — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how WeightCare is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
WeightCare is a Florida-based telehealth provider selling compounded semaglutide and tirzepatide dispensed by FDA-registered, PCAB-accredited pharmacies, with quality-testing documentation published for potency and sterility. It claims tens of thousands of members since 2022. Unusually for this category it publishes actual milligram bands against its prices on both molecules, including a microdose band, though those bands live in rendered storefront comparison tables rather than in its product data. Plans are sold as month-to-month, three-month and six-month terms, and the high-dose tirzepatide tier is not sold monthly at all.
The honest cons
The comparison strip advertises three figures side by side of which only the highest is a month-to-month rate — the other two are three- and six-month prepay rungs presented in the same visual register, which is the single most misleading thing on the site
- The discounted three-month tirzepatide rate is a starter price that renews substantially higher, and the renewal figure is not shown next to the offer
- The high-dose tirzepatide tier is not sold monthly at all — only as a three- or six-month prepay — so a titrating patient hits a mandatory commitment they were not warned about
- The milligram bands appear only in rendered storefront comparison tables and are absent from the product data entirely, so the most valuable thing on the site is also the least durable
- The named microdose band on tirzepatide tops out at 5 mg/week, which is a standard maintenance dose rather than a microdose by any usual reading
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
WeightCare is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs to compare with WeightCare. Both are partners: we may earn a commission if you start care through these links.
Partner
ShedRx (Shed)
$149–$199/mo microdose (2-month minimum)
Charges less for less
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Where this sits
#60 of 548
Ordered with the companies that pay us first, and WeightCare is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Microdosing tirzepatide
- Microdosing semaglutide
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Enhance MD
$169–$189/mo micro tirz (3–12-mo plans)
- Vs median
- $6/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Charges less for less
- Dispensed
- Compounded by Tru Meds Rx · Strive Pharmacy · Pharmacy Hub
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Enhance MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.